Further to the communication dated July 13, 2026, pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) Zenotech Laboratories has informed that the Meeting of the Board of Directors of the Company was held today, July 28, 2026, which commenced at 11:30 AM and concluded at 2:30 PM, IST. The Board has, 1. Approved Unaudited Standalone Financial Results - The Unaudited Standalone Financial Results for the quarter ended June 30, 2026, as approved pursuant to Regulation 33 of the Listing Regulations, along with the Limited Review Report of the Statutory Auditors, are annexed herewith as Annexure A. 2. Approved convening 37th Annual General Meeting - The 37th Annual General Meeting (‘AGM’) of the Company will be held on Friday, September 25, 2026, at 10:30 AM IST through Videoconferencing. The Notice of the AGM and the Annual Report will be released in due course. Shareholders are requested to get their information updated with the depositories (for shares held in demat) or with the Company’s RTA (for shares held in physical form), so that Notice of the AGM and the Annual Report can be received by email.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.00 |
| Dr. Reddys Labs. | 1198.95 |
| Cipla | 1461.55 |
| Lupin | 2264.70 |
| Zydus Lifesciences | 1204.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: